ANI Pharmaceuticals | ANIP - Passivo Circulante





Passivo Circulante Alterar Data
AbbVie USD 42.1B 1.19B 2026-03
ANI Pharmaceuticals USD 239.51M 38.6M 2026-03
Aurora Cannabis CAD 66.93M 79M 2026-03
Canopy Growth CAD 158.44M 60.15M 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Heron Therapeutics USD 90.52M 5.58M 2026-03
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Omeros USD 85.5M 2.28M 2025-06
Perrigo USD 997.6M 15.3M 2026-03
Sun Pharmaceuticals INR 226.22B 7.93B 2026-03
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03